Search

everythinglearnresearchcommunity

for

Search:↓

Folliculotropic mycosis fungoides can affect the central nervous system in advanced stages.

Mycophenolate mofetil is safer and more effective than cyclophosphamide for treating lupus nephritis.

Topical tacrolimus did not regrow hair in alopecia universalis patients.

Betamethasone dipropionate reduced skin thickness, fish oil increased it, and combined treatment had no significant effect.

Mycophenolic acid effectively improved hair and nail growth in a lupus patient.

The formulated gel is a promising treatment for alopecia areata.

Tofacitinib may slow hair loss in scarring alopecias but is unlikely to regrow significant hair.

Topical JAK inhibitors may help treat alopecia universalis by promoting hair regrowth.

A woman on immunosuppressants developed two rare scalp conditions, which improved with specific treatments.

Tofacitinib helped regrow hair in a patient with severe hair loss and improved their quality of life without side effects.

Hair thinning is a common but generally mild and reversible side effect of teriflunomide in multiple sclerosis patients.

Farudodstat may help prevent hair loss in alopecia areata by stopping immune attacks on hair follicles.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

Oral tofacitinib is a promising treatment for beard hair loss in alopecia areata.

Hair regrowth was achieved using 5-Fluorouracil and Bleomycin for scalp atrophy caused by corticosteroids.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

Ritlecitinib effectively regrows hair in severe alopecia areata and is well tolerated.

Rituximab may cause skin issues, but baricitinib can help improve them.

Baricitinib helps alopecia areata and may improve psoriasis, but its effect on psoriatic arthritis is unclear.

Baricitinib helps regrow hair and improves quality of life and mental health in severe alopecia areata patients.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

Frontal fibrosing alopecia is a challenging hair loss condition with no known cause or definitive treatment.

Targeting SIRT1 with antisense oligonucleotides could be a promising treatment for hair loss.

Betamethasone valerate foam is more effective and safe for treating mild-to-moderate alopecia areata than betamethasone dipropionate lotion.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Baricitinib treatment helped reduce hair loss symptoms in mice by decreasing inflammation-related immune cells.

Tofacitinib is effective and safe for treating alopecia areata with a good drug survival rate.

Biologics and small molecules can effectively treat inflammatory nail disorders, but personalized treatment plans are important.

Baricitinib helps regrow hair in teens with severe alopecia areata.